(Q34342536)

1 August 2017

title

Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors (English)

1 reference

1 August 2017

1 reference

Antony R Knight

1

1 reference

1 August 2017

Anil Misra

2

1 reference

1 August 2017

Kathleen Quirk

3

1 reference

1 August 2017

Karen Benwell

4

1 reference

1 August 2017

Dean Revell

5

1 reference

1 August 2017

Guy Kennett

6

1 reference

1 August 2017

Mike Bickerdike

7

1 reference

1 August 2017

publication date

30 July 2004

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

370

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

114-123

1 reference

https://scigraph.springernature.com/pub.10.1007/s00210-004-0951-4

1 August 2017

exact match

0 references

cites work

Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors

1 reference

12 December 2020

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

1 reference

12 December 2020

BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats

1 reference

12 December 2020

Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature

1 reference

12 December 2020

A proposed new nomenclature for 5-HT receptors.

1 reference

12 December 2020

Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist

1 reference

12 December 2020

5-HT2 receptor subtypes: a family re-united?

1 reference

12 December 2020

Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle

1 reference

12 December 2020

Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonists

1 reference

12 December 2020

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro

1 reference

12 December 2020

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis

1 reference

12 December 2020

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)

1 reference

12 December 2020

Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors

1 reference

12 December 2020

Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors

1 reference

12 December 2020

Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities

1 reference

12 December 2020

Characterisation of agonist binding on human 5-HT2C receptor isoforms

1 reference

12 December 2020

Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.

1 reference

12 December 2020

Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells

1 reference

12 December 2020

Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice

1 reference

12 December 2020

LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.

1 reference

12 December 2020

Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences

1 reference

12 December 2020

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

12 December 2020

5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro

1 reference

12 December 2020

A review of central 5-HT receptors and their function

1 reference

12 December 2020

Multiple serotonin receptors: clinical and experimental aspects

1 reference

12 December 2020

Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system

1 reference

12 December 2020

Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action

1 reference

12 December 2020

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

12 December 2020

Multiple serotonin receptors: opportunities for new treatments for obesity?

1 reference

12 December 2020

Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.

1 reference

12 December 2020

(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity

1 reference

12 December 2020

Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.

1 reference

12 December 2020

Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists

1 reference

12 December 2020

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS.

1 reference

12 December 2020

High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action

1 reference

12 December 2020

Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

1 reference

12 December 2020

5-HT2C receptor agonists as potential drugs for the treatment of obesity

1 reference

12 December 2020

Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder

1 reference

12 December 2020

Indoline derivatives as 5-HT(2C) receptor agonists.

1 reference

12 December 2020

Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor

1 reference

12 December 2020

Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptors

1 reference

12 December 2020

Differential radioligand binding properties of [3H]5-hydroxytryptamine and [3H]mesulergine in a clonal 5-hydroxytryptamine1C cell line

1 reference

12 December 2020

5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function

1 reference

12 December 2020

Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

1 reference

12 December 2020

[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine

1 reference

12 December 2020

The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors

1 reference

12 December 2020

Pharmacological characterisation of human 5-HT2 receptor subtypes

1 reference

12 December 2020

Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors

1 reference

12 December 2020

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

1 reference

12 December 2020

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

1 reference

12 December 2020

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

1 reference

12 December 2020

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

12 December 2020

Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol

1 reference

12 December 2020

Behavioral effects of AMI-193, a 5-HT(2A)- and dopamine D(2)-receptor antagonist, in the squirrel monkey

1 reference

12 December 2020

10.1007/S00210-004-0951-4

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1044851488

0 references

1 reference